Metropolis Healthcare IPO is a Book Building listing on BSE,NSE exchange, with an ipo size of ₹ 1204.29 Cr. The company is based in Mumbai and caters to Healthcare sector. Credit Suisse Securities (India) , Goldman Sachs (India) Securities , Hdfc Bank , Jm Financial are the merchant bankers of Metropolis Healthcare IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on 27th September 2018.
Metropolis Healthcare IPO posted revenues of ₹ 745.73 Cr. and PAT of ₹ 118.36 Cr. in FY19 on annualised basis.Financial results of Metropolis Healthcare IPO based on restated financials as per prospectus and IPO review parameters can be referred to below.
Financials | Dec-18 | FY 18 | FY 17 | FY 16 | |
---|---|---|---|---|---|
Balance Sheet
|
|||||
Assets | 583.87 | 530.34 | 515.15 | 395.91 | |
Net Worth | 470.31 | 429.13 | 344.15 | 293.88 | |
Total Debt | 0.31 | 0.57 | 0.76 | 0.84 | |
Profit & Loss
|
|||||
Revenue
Revenue on annualised basis |
559.30
745.73 |
643.56 | 544.72 | 475.46 | |
EBITDA
EBITDA on annualised basis |
103.83
138.44 |
180.51 | 177.52 | 144.95 | |
PAT
PAT on annualised basis |
88.77
118.36 |
109.74 | 107.25 | 81.95 |
Metropolis Healthcare IPO PAT Margin is 15.87 % , ROCE (Return on Capital Employed) is [●] % as per latest financial. The below table shows Metropolis Healthcare IPO Key Performance Indicators (KPI) as mentioned in company’s prospectus.
Particulars | Dec-18 | FY 18 | FY 17 | FY 16 |
---|---|---|---|---|
EBITDA Margin (%) | 18.56 | 28.05 | 32.59 | 30.49 |
PAT Margin (%) | 15.87 | 17.05 | 19.69 | 17.24 |
EPS (₹) | 17.18 | 20.61 | 20.48 | 15.25 |
ROE (%) | 18.87 | 25.57 | 31.16 | 27.89 |
ROCE (%) | [●] | [●] | [●] | [●] |
ROA (%) | 15.20 | 20.69 | 20.82 | 20.70 |
Debt to Equity | 0.00 | 0.00 | 0.00 | 0.00 |
The market Capitalisation of Metropolis Healthcare IPO is ₹ 0.00 crores at the time of IPO and other IPO valuation metrics of this IPO is mentioned below.
The Metropolis Healthcare IPO prospectus highlights an Return on Equity (ROE) of 18.87 % , Return on Assets (ROA) of 15.20 %, and an EBITDA Margin of 18.56 %, showcasing financial performance.
Profitability ratios like Return on Equity (ROE), Return on Assets (ROA), and Net Profit Margin shows Metropolis Healthcare IPO financial report. Analysing these metrics can provide insights into the company’s efficiency, profitability, and long-term growth potential.
The post-IPO market capitalisation of Metropolis Healthcare IPO is ₹ 0.00 Cr., based on the issue price and share structure. It helps investors gauge the company’s valuation and compare it with industry peers before investing.
The Metropolis Healthcare IPO has a Price-to-Earnings (PE) ratio of 37.30 X, indicating valuation compared to industry peers. It helps investors determine if the stock is overvalued or undervalued compared to its earnings and industry peers.
Metropolis Healthcare IPO reported revenue of ₹ 745.75 Cr. in the latest fiscal year, showing business performance, on annualised basis. Revenue figures from Metropolis Healthcare IPO provide insights into sales growth, market demand, and business scalability.
Metropolis Healthcare recorded an EBITDA of ₹ 138.44 Cr., reflecting operational efficiency. EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortisation) measures operational profitability.
Metropolis Healthcare Profit After Tax (PAT) is ₹ 118.36 Cr., reflecting earnings growth. Profit After Tax (PAT) reflects the company’s actual earnings after all expenses, taxes, and deductions
Metropolis Healthcare operates in Healthcare and Healthcare Analytical Services. The Issue is listed on BSE,NSE in Apr, 2019. Metropolis Healthcare IPO size was 1204.29 with Issue price of 880.00 .
Merchant Banker(s) of Metropolis Healthcare IPO: Credit Suisse Securities (India) Private Limited , Goldman Sachs (India) Securities Private Limited , Hdfc Bank Limited , Jm Financial Limited
Metropolis Healthcare IPO subscription was 5.83 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Metropolis Healthcare IPO listed at a listing price of 959.55 against the offer price of 880.00.
The current market price of Metropolis Healthcare is 1938.70.
Why Us?